English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1419]
News [1460]
Articles [101]
Editorials [24]
Conferences [146]
elearning [1]
Making mammography inclusive for patients with disabilities
Making mammography inclusive for patients with disabilities
WCLC 2023: CheckMate 227 survival and QoL benefits unveiled for patients with metastatic NSCLC and nivolumab + ipilimumab treatment
WCLC 2023: CheckMate 227 survival and QoL benefits unveiled for patients with metastatic NSCLC and nivolumab +...
WCLC 2023: Exhaled breath analysis shows promise in detecting malignant pleural mesothelioma
WCLC 2023: Exhaled breath analysis shows promise in detecting malignant pleural mesothelioma
WCLC 2023: KRYSTAL-1 trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations
WCLC 2023: KRYSTAL-1 trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C...
Researchers show results of CAR-T-cell therapy without side effects in preclinical models
Researchers show results of CAR-T-cell therapy without side effects in preclinical models
The appropriate use of Lu-177 PSMA-617 radionuclide therapy
The appropriate use of Lu-177 PSMA-617 radionuclide therapy
A free online tool can help prostate cancer patients save on out-of-pocket drug costs
A free online tool can help prostate cancer patients save on out-of-pocket drug costs
First-in-class targeted microRNA therapy slows cancer tumour growth
First-in-class targeted microRNA therapy slows cancer tumour growth
European Commission approves pembrolizumab plus trastuzumab and chemotherapy as first-line treatment for HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma expressing PD-L1
European Commission approves pembrolizumab plus trastuzumab and chemotherapy as first-line treatment for HER2...
Researchers publish key findings about cell proteins to determine effectiveness of immunotherapy for colon cancer
Researchers publish key findings about cell proteins to determine effectiveness of immunotherapy for colon cancer
<1...1718192021...146>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top